Comprehensive medication guide to {drug} including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Focalin XR (Dexmethylphenidate Hydrochloride extended-release) is a prescription CNS stimulant medication approved by the FDA for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 years and older. It is manufactured by Novartis Pharmaceuticals and is available in both brand-name and generic forms.
Focalin XR is the extended-release version of Focalin, designed to be taken once daily in the morning. The capsules use a dual-bead technology that releases half the dose immediately and the other half approximately 4 hours later, providing up to 12 hours of symptom control.
Dexmethylphenidate is the more pharmacologically active d-threo enantiomer of Methylphenidate (the active ingredient in Ritalin and Concerta), which means it may provide equivalent efficacy at roughly half the dose of racemic Methylphenidate.
Focalin XR works by blocking the reuptake of two key neurotransmitters — dopamine and norepinephrine — into presynaptic neurons in the brain. By preventing these neurotransmitters from being reabsorbed, Focalin XR increases their availability in the extraneuronal space, particularly in the prefrontal cortex.
This enhanced dopamine and norepinephrine signaling improves attention, focus, and impulse control — the core symptoms of ADHD. The extended-release capsule uses a bimodal release mechanism: approximately 50% of the dose is released immediately, with the remaining 50% released about 4 hours later, mimicking twice-daily dosing in a single capsule.
Most adults are prescribed between 10 mg and 40 mg daily. Children aged 6 and older typically start at 5 mg/day and may be increased in 5 mg increments weekly up to 30 mg/day.
Focalin XR has a findability score of 35 out of 100, meaning it is currently very difficult to find in stock at most pharmacies. The broader ADHD stimulant shortage that began in October 2022 continues to affect Dexmethylphenidate ER products in 2026. Multiple manufacturers have limited supply across various strengths, and many pharmacies experience intermittent stock-outs.
Patients may need to call multiple pharmacies, check independent pharmacies, or use tools like Medfinder to locate Focalin XR in stock near them. Some strengths may be more available than others, so ask your prescriber about dose flexibility.
Struggling to find {drug} in stock? We'll call the pharmacies, sit on hold, and find you one that can fill your prescription.

As a Schedule II controlled substance, Focalin XR must be prescribed by a licensed healthcare provider with prescribing authority. Common prescribers include:
Telehealth providers can also prescribe Focalin XR in many states, though some states have restrictions on prescribing Schedule II stimulants via telemedicine. Use Medfinder to find prescribers near you.
Yes. Focalin XR is classified as a Schedule II (CII) controlled substance by the DEA. This is the most restrictive category for medications with accepted medical use, indicating a high potential for abuse and dependence.
Because of its Schedule II status:
The boxed warning on Focalin XR states that CNS stimulants have a high potential for abuse and dependence, and prescribers should assess abuse risk before prescribing and monitor patients during therapy.
Like all stimulant medications, Focalin XR can cause side effects. Most are mild and may improve over time. Common side effects include:
Serious side effects that require immediate medical attention include:
Contact your doctor if side effects are persistent or concerning. Regular monitoring of blood pressure, heart rate, and growth (in children) is recommended.
If you cannot find Focalin XR in stock or need to switch medications, these are common alternatives your doctor may consider:
Always consult your prescriber before switching medications. Do not stop taking Focalin XR abruptly without medical guidance.
Focalin XR can interact with several classes of medications. Always inform your doctor about all medications, supplements, and herbal products you take.
Major interactions (avoid combining):
Moderate interactions (use with caution):
Focalin XR remains an effective and widely prescribed treatment for ADHD, but the ongoing stimulant shortage makes finding it in stock a real challenge for patients in 2026. With a findability score of just 35 out of 100, many patients are forced to call multiple pharmacies or go without their medication.
If you're struggling to find Focalin XR, try using Medfinder to check real-time pharmacy availability near you. You can also save money with coupons from GoodRx or SingleCare, which can bring the generic price down to as low as $30 for a 30-day supply. If cost is a barrier, explore Novartis's patient assistance program through NeedyMeds or RxAssist.
Talk to your prescriber about alternatives if you consistently cannot fill your Focalin XR prescription — there are several effective ADHD medications that may be easier to find in stock.